mourad drug corp.

283 commack road
commack, new york 11725

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 19, 2014

NYS DOS ID#
4579056

County
SCHOHARIE

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - MOURAD DRUG CORP.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • The New War on (Overpriced) Drugs
    By David Ferry - Saturday Jun 10, 2017

    Drug prices are too high. Meet the man who could fix them and the surprising opponents who want him to go away.

    Source: Webmonkey
  • FDA tells drug maker to pull powerful opioid off the market
    By Beth Mole - Friday Jun 9, 2017

    Risks outweigh benefits for opioid linked to abuse and disease outbreaks, agency says.

    Source: Ars Technica
  • Seizing on Opioid Crisis, a Drug Maker Lobbies Hard for Its Product
    By ABBY GOODNOUGH and KATE ZERNIKE - Sunday Jun 11, 2017

    Despite limited evidence to prove its drug works, the maker of Vivitrol has used political connections and marketing to push for its use for detoxing.

    Source: NYT > Home Page
  • Opioid Dealers Embrace the Dark Web to Send Deadly Drugs by Mail
    By NATHANIEL POPPER - Saturday Jun 10, 2017

    Anonymous online sales are surging, and people are dying. Despite dozens of arrests, new merchants — many based in Asia — quickly pop up.

    Source: NYT > Home Page
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Drug Prices: This Time Is Different
    Monday Jun 12, 2017

    Yet another congressional hearing on drug prices is on tap. Investors should resist the temptation to ignore it.

    Source: The Wall Street Journal: Markets News
  • Draft Order on Drug Prices Proposes Easing Regulations
    By SHEILA KAPLAN and KATIE THOMAS - Tuesday Jun 20, 2017

    A draft of an executive order obtained by The Times appears to give the drug industry what it wants with no guarantee that consumer costs will fall.

    Source: NYT > Home Page